Annual Report 2022

2022 Annual Report

From Frontier Technology to Groundbreaking Discoveries

Mouse Scroll

In 2022, technological advancements and scientific talent have propelled our scientific progress to unprecedented heights, generating groundbreaking discoveries and enabling us to explore new frontiers and drive innovation in the biomedical field.

2022 in numbers

book

71.5%

PUBLICATIONS IN D1 JOURNALS

coins

€31.2M

BUDGET

microscope

28

RESEARCH GROUPS

Research

book

182

SCIENTIFIC PUBLICATIONS

This year, remarkable progress has been made in research into cancer and metastasis, and ageing- and metabolism-related disorders. We also advanced our fundamental understanding of the mechanisms underlying health and disease. Our research has had a great impact both on the scientific community and society at large.

Scientific projects

medal

€17.5M

EXTERNAL FUNDING

Here are some notable projects that have been awarded funding in 2022 through both competitive and non-competitive calls run by public and private entities. These and other strategic projects have been advanced using state-of-the-art technologies, such as machine learning, artificial intelligence, and single cell-sequencing.

Innovation

building

6

ACTIVE SPIN-OFFS

Our spin-offs have made significant contributions to the industry, generating important news and advancements. The groundbreaking discoveries made by our research groups have resulted in licensing agreements, patent filings, and the acquisition of competitive international funding.

Catalan National Innovation Award for the foundation of Ona Therapeutics
Catalan National Innovation Award for the foundation of Ona Therapeutics

The Government of Catalonia and the Catalan Foundation for Research and Innovation has awarded IRB Barcelona the “…

Inbiomotion
Inbiomotion validates its test, which will help reduce mortality in breast cancer

Inbiomotion, a spin-off from IRB Barcelona, developed a unique single-gene-based biomarker for the personalised…

Sant Joan de Déu Pediatric Hospital
Gate2Brain €2.5M funding - EIC Accelerator

IRB Barcelona's spin-off Gate2Brain has received a grant from the EIC Accelerator Programme.  Run by the…

People & Talent

couple

469

PROFESSIONALS

Our institution draws exceptionally talented scientists from Spain and beyond into its community. The remarkable contributions  of these researchers have garnered recognition and numerous awards from various distinguished organisations, thereby showcasing their outstanding international standing.

Communications & Public Engagement

speaker

3,172

Impacts in media

Our scientific discoveries have sparked widespread interest in the media, including specialist and generalist journals, TV and radio programs, and online platforms, thus leading to an unprecedented media impact.

microphone

>8K

PEOPLE REACHED THROUGH PUBLIC ENGAGEMENT ACTIVITIES

We have always stood by the significance of public engagement with science. This year we have celebrated 10 years of the Crazy About Biomedicine Programme, which promotes scientific vocations among tomorrow’s leaders.

Fundraising

logo icon

€2.58M

Raised since the launch of the Metastasis Challenge

The Metastasis Challenge is not just a fundraising campaign but a powerful movement that unites people and organisations in the fight against metastatic cancer. Thanks to the generous support received, we have raised €2.58M to fund groundbreaking research that brings hope to millions of people affected by this devastating disease.

Thank you!

We would like to thank all the people and institutions who have made 2022 an exceptional year. Thanks to your contributions, our science is bringing about biomedical breakthroughs that have an increasing impact on people's lives. We would also like to thank all the people and organisations who have joined the Metastasis Challenge.

Every donation, every event, every legacy helps us get one step closer to our goal of stopping metastasis.

DONATE